Your browser doesn't support javascript.
loading
SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.
Nakahara, Yukiko; Yamane, Mariko; Sunada, Midori; Aoyama, Yumi.
Affiliation
  • Nakahara Y; Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
  • Yamane M; Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
  • Sunada M; Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
  • Aoyama Y; Department of Dermatology, Kawasaki Medical School, Okayama, Japan.
J Dermatol ; 50(2): 162-165, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36578130
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Cutaneous / Pemphigoid, Bullous / Dipeptidyl-Peptidase IV Inhibitors / COVID-19 Vaccines / COVID-19 / Lupus Erythematosus, Systemic Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Dermatol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Cutaneous / Pemphigoid, Bullous / Dipeptidyl-Peptidase IV Inhibitors / COVID-19 Vaccines / COVID-19 / Lupus Erythematosus, Systemic Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Dermatol Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido